201652 Measles in the United States, 2008

Tuesday, November 10, 2009: 8:50 AM

Gregory Wallace, MD, MS, MPH , National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Amy A. Parker, MSN, MPH , Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Susan B. Redd , Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Kathleen M. Gallagher, DSc, MPH , Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Paul Rota, PhD , Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Jennifer Rota, MPH , Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
William J. Bellini, PhD , Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Measles is a highly infectious viral disease. Before the measles vaccine program, 450 deaths and 48,000 hospitalizations occurred annually from measles in the U.S. Due to high vaccination coverage, measles was declared eliminated from the U.S. in 2000. However, in 2008, 140 measles cases were reported from 19 states, the highest number since 1996. We reviewed the epidemiology of measles cases reported to the Centers for Disease Control and Prevention throughout 2008 to examine potential explanations for the increase. Seventeen (12%) case-patients, including six children too young for vaccination, were hospitalized. Case-patients ranged in age from 5 months to 71 years; 20 (14%) were aged <1 year, 28 (20%) were 1-4 years, and 59 (42%) were 5-19 years. Of the 127 U.S. residents with measles, 116 (91%) were unvaccinated or had unknown vaccination status, 4 (3%) had one dose, and 7 (6%) had 2 doses of MMR vaccine. Among the 116 unvaccinated U.S. residents with measles, 18 (16%) were ineligible because of age. Of the 98 vaccine-eligible case-patients, 67 (68%) were unvaccinated because of philosophical or religious beliefs. Approximately 90% (126/140) of cases were import-associated, including many from the World Health Organization European Region. The 2008 U.S. measles upsurge was characterized by spread from imported cases and a high proportion of cases in persons claiming vaccine exemptions. With large measles outbreaks in Europe and elsewhere, and unvaccinated persons clustered geographically in the U.S., imported virus and subsequent spread continue to remain a risk for further U.S. measles outbreaks.

Learning Objectives:
Describe the epidemiology of measles in the United States in 2008 and identify reasons for the increase in U.S. measles cases.

Keywords: Immunizations, Epidemiology

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Dr. Wallace is currently a Research Medical Officer in the Measles, Mumps, Rubella, and Polio team in the Epidemiology Branch of the Division of Viral Diseases at the National Center for Immunization and Respiratory Diseases (NCIRD) in the United States Centers for Disease Control and Prevention (CDC). Dr. Wallace joined CDC in October 2000 where he has worked on Pandemic Influenza Planning, Pertussis Epidemiology and Surveillance, the Recommended Childhood and Adolescent Immunization Schedule, and issues pertaining to Vaccine Storage and Handling. He was also previously lead of activities for publicly procured vaccines for CDC including implementing the vaccine program through securing contracts, monitoring ordering and distribution, and responding to Vaccine Shortages. His previous positions in CDC include Medical Officer at the National Vaccine Program Office (NVPO) and in the Epidemiology & Surveillance Division in the National Immunization Program (NIP), and as Chief of the Vaccine Supply & Assurance Branch at the National Center for Immunization and Respiratory Diseases (NCIRD) in the United States Centers for Disease Control and Prevention (CDC). He obtained his M.D. degree from Georgetown University in Washington, D.C. He is board certified in Family Practice and in General Preventive Medicine and Public Health. He was in private practice in California prior to preventive medicine training at Johns Hopkins University where he also received his M.P.H. degree.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.